Comparison of long-term outcomes and risk factors of aortic stenosis treatment in patients undergoing transcatheter aortic valve implantation and surgical aortic valve replacement
Author(s) -
Karolina Marzec,
Maria Jaworska-Wilczyńska,
Ilona Kowalik,
Małgorzata Nieznańska,
Adam Witkowski,
Maciej Dąbrowski,
Krzysztof Kuśmierski,
Tomasz Hryniewiecki
Publication year - 2022
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.a2022.0122
Subject(s) - medicine , aortic valve replacement , cardiology , euroscore , atrial fibrillation , stenosis , stroke (engine) , propensity score matching , copd , retrospective cohort study , heart failure , aortic valve , cardiac surgery , mechanical engineering , engineering
Aortic stenosis (AS) is the most common valvular heart disease and untreated has a bleak prognosis. The only effective method of treatment is valve replacement, surgical (SAVR), or transcatheter (TAVI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom